Founded in 2009 and headquartered in Broomfield, Colorado, Flagship Biosciences, Inc. is a data-centric pathology services company delivering the most accurate and informative data. We are revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI. Our patented technology and proprietary workflow significantly improve on the data and interpretation from traditional pathology methods. We eliminate the variability associated with typical assessments and bring new insights to tissue analysis. With expert scientific consultation for every client, our team interprets results, contextualizes tissue biology, and identifies the best course for success.
Location: United States, Colorado, Broomfield
Employees: 51-200
Founded date: 2009
Investors 1
| Date | Name | Website |
| 15.09.2022 | BroadOak C... | broadoak.c... |
Mentions in press and media 11
| Date | Title | Description |
| 24.01.2024 | Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics | Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics Wed, Jan 24, 2024 08:00 CET Report this content Unlocking the combined value of... |
| 09.03.2023 | Flagship Biosciences appoints Gina Wallar, Ph.D., MPH as new Chief Commercial Officer | Flagship is a company dedicated to the best science, and Dr. Wallar's passions for both science and business make her the perfect choice for our CCO. BROOMFIELD, Colo. (PRWEB) March 09, 2023 Flagship Biosciences, Inc., a leader in spatial b... |
| 07.02.2023 | Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development | Flagship Biosciences' biomarker data services are critical to informing precision medicine decisions, and together with Genomenon's disease-specific genomic datasets powered by the Mastermind knowledgebase, the two companies provide unique ... |
| 30.09.2022 | Flagship Biosciences hires Tom Turi, Ph.D. as CSO | Flagship Biosciences hired industry veteran Tom Turi as Chief Scientific Officer. Tom will help grow the company’s spatial biology and biomarker analytics business and expand strategic partnerships supporting customers’ therapeutic developm... |
| 02.09.2022 | Shanghai-based cell therapy biotech nabs new funds; Colorado biotech nets an acquisition | A Lilly Asia Ventures-backed cell therapy biotech has secured $50 million in Series A funds to bankroll CAR-NK therapies. At the helm of the Shanghai-based Neukio Biotherapeutics is a leader with experience in the CAR-T cel... |
| 01.06.2021 | Flagship Biosciences Expands Tissue Image Analysis Capabilities at New Colorado Location in Support of Pharmaceutical and Clinical Clients | Flagship Biosciences, Inc. "Our new laboratory setup and additional space will empower our teams to continue to collaborate and as we revolutionize tissue analysis to improve drug development and diagnostics." Trevor Johnson, Flag... |
| 10.03.2021 | Flagship Biosciences Announces Strategic Executive Team Additions | Both of these exceptional leaders are advancing Flagship’s strategic capabilities. I am excited for the future of our work together and for the benefits that our clients will realize. WESTMINSTER, Colo. (PRWEB) March 10, 2021 Flagship Biosc... |
| 25.06.2020 | Что нужно учесть, инвестируя в ИИ? | Воплощение многогранных возможностей ИИ в реальность способно не только значительно улучшить качество жизни многих людей, но и принести прибыль. Давайте обсудим самые интересные тренды в мире ИИ, чтобы разобраться в какие проекты стоит инве... |
| 11.07.2018 | Flagship Biosciences Closes Series A Funding | Flagship Biosciences, a Westminster, CO-based provider of computational tissue image analysis technology and services, closed a series A round of funding. The amount of the deal was not disclosed. The company intends to use the funds to adv... |
| - | Flagship Biosciences | “Flagship Biosciences provides a critical advantage in tissue diagnostic and image analysis testing for drug development and pharmaceutical research.” |
Show more